Aptinyx   Report issue

For profit Phase 2
Founded: Evanston IL United States (2015)

Organization Overview

First Clinical Trial
2016
NCT02834741
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Aptinyx | Aptinyx Inc.